1. Japan Stocks

  2. •

    Process industries

  3. •

    Chemicals: specialty
DKS Co. Limited

DKS Co. Limited

TTSE:4461
12,410.00
JPY
-890.00
(-6.69%)
78.73BMarket Cap
Oct 29Next Earn
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
6,398.98
6,035.02
4,998.11
4,974.87
5,612.44
5,864.74
6,044.65
5,813.43
6,155.78
6,683.58
6,598.16
7,651.45
8,146.04
- -
Basic EPS, GAAP
156.54
193.43
208.14
236.97
330.21
254.09
198.09
251.94
244.77
-41.8
122.73
270
606.29
- -
Free Cash Flow per Basic Share
172.94
-78.48
-343.93
-14.28
247.54
-46.37
-174.29
54.75
280.82
-216.69
479.72
562.77
623.1
- -
Dividend per Share
32.46
32.35
44.88
50.08
59.72
69.8
104.95
69.99
69.93
86.26
59.9
89.93
114.1
- -
Book Value per Share
2,201.78
2,363.07
2,425.9
2,650.05
2,970.51
3,082.57
3,114.65
3,404.9
3,610.06
3,593.31
3,839.73
4,044.35
4,904.12
- -
Tangible Book Value per Share
2,148.73
2,296
2,374.06
2,611.86
2,933.28
2,949.91
3,003.54
3,323.04
3,549.38
3,557.63
3,809.43
4,018.24
4,878.86
- -
Basic Weighted Avg Shares
9
9
11
11
10
10
10
10
10
10
10
10
10
10
Sales/Revenue/Turnover
54,614
55,597
52,782
52,254
56,955
59,574
61,456
59,140
62,672
65,081
63,118
73,255
82,886
- -
Operating Margin (%)
4.54
5.3
6.52
7.55
8.87
7.29
6.76
7.59
7.38
1.83
3.29
7.31
12.2
- -
Depreciation Expense
2,088
2,154
2,087
2,335
2,473
2,665
2,920
3,459
3,580
3,508
3,216
3,223
3,221
- -
Net Income, GAAP
1,336
1,782
2,198
2,489
3,351
2,581
2,014
2,563
2,492
-407
1,174
2,585
6,169
- -
Effective Tax Rate (%)
36.24
30.04
29.5
25.77
27.16
29.35
30.11
26.87
27.26
122.32
29.88
26.43
26.2
- -
Profit Margin (%)
2.45
3.21
4.16
4.76
5.88
4.33
3.28
4.33
3.98
-0.63
1.86
3.53
7.44
- -
Working Capital
7,931
15,198
11,707
15,400
17,875
15,141
18,951
21,926
24,808
24,772
28,455
30,715
29,820
- -
LT Debt
10,868
14,979
15,959
19,412
18,240
17,359
23,201
24,809
23,602
25,479
26,773
24,526
14,674
- -
Total Equity
19,886
26,156
26,745
28,044
31,958
33,589
34,264
37,402
40,382
38,295
41,295
44,503
58,256
- -
Return on Invested Capital (%)
3.88
4.5
4.79
5.51
6.58
5.28
4.67
4.82
4.74
-0.37
1.97
5.12
8.95
- -
Return on Capital (%)
3.55
4.11
4.9
4.85
5.19
4.35
2.97
3.8
3
-1.15
1.24
2.02
6.43
- -
Return on Common Equity (%)
7.41
8.15
8.69
9.48
11.75
8.4
6.39
7.73
6.98
-1.14
3.3
6.85
13.59
- -

Capital Structure

JPY

•

in mil. unless spec.
Sep'26
Mar'26
Jun'27
ST Debt
8,575
14,470
- -
LT Borrowings
20,172
14,431
- -
LT Finance Leases
310
243
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
11
11
11
Market Capitalization
62,537
78,734
130,301

Working Capital

JPY

•

in mil. unless spec.
Sep'26
Mar'26
Jun'27
Total Current Assets
60,652
69,382
- -
Cash, Cash Equivalents & STI
19,768
24,031
- -
Accounts Receivable, Net
19,152
21,364
- -
Inventories
16,790
18,723
- -
Total Current Liabilities
28,049
39,562
- -
Payables & Accruals
- -
- -
- -
ST Debt
8,575
14,470
- -
Deferred Revenue
- -
- -
- -

Growth Rates

JPY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
8.44%
9.86%
30.9%
Free Cash Flow
-188.74%
-8.58%
17.67%
Net Income, GAAP
-21.85%
-49.74%
138.65%
Sales/Revenue/Turnover
4.8%
7.2%
13.15%
Total Cash Common Dividend
- -
- -
34.84%

Quarterly Revenue

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
73,255
2026
- -
- -
- -
- -
82,886
2027
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
270
2026
- -
- -
- -
- -
606.29
2027
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
89.93
2026
- -
- -
- -
- -
114.1
2027
- -
- -
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Naoki Yamaji
Full Time Employees
1,155
Sector
Process industries
Industry
Chemicals: specialty
Address
48-2 Higashikujo-Kamitonodacho Kyoto KY Japan 601-8002
IPO Date
May 16, 1949
Website
dks-web.co.jp
Similar Companies
Petkim Petrokimya Holding Anonim Sirketi (BIST:PETKM)
Albemarle Corporation (NYSE:ALB)
Linde plc (NASDAQ:LIN)
Gubre Fabrikalari T.A.S. (BIST:GUBRF)
IOL Chemicals & Pharmaceuticals Ltd. (NSE:IOLCP)
PI Industries Limited (NSE:PIIND)
Business
DKS Co. Ltd. is a Japan-based company primarily engaged in the production and sale of surfactants, other industrial chemicals, and life sciences-related products. Its business operations are divided into five key segments: surfactants (including nonionic, anionic, cationic, and amphoteric surfactants); amenity materials (such as sucrose fatty acid esters, cellulose-based polymer materials, vinyl-based polymer materials, and health supplements); urethane materials (polyether polyols, urethane prepolymers, and urethane systems); functional materials (materials for photocurable resins, aqueous urethane resins, flame retardants, and amide-based lubricants); and electronic device materials (conductive pastes for electronic components and pellets for injection molding). The company serves a broad range of industrial fields and markets its products both domestically and internationally. Founded in August 1918, DKS Co. Ltd. is headquartered in Kyoto, Japan. In recent developments, DKS Co. Ltd. has shown a strong financial turnaround in 2024, with net sales increasing by 21.3% to approximately ¥35.4 billion and a significant operating income improvement to ¥2.47 billion in the first half of the year. The company’s equity ratio improved to 40.7%, reflecting a stronger financial foundation. Additionally, DKS is advancing its research and product offerings through joint research projects, including a notable collaboration with D. Western Therapeutics Institute, Inc. aimed at developing new solutions in the life sciences sector. These efforts underline strategic growth in both industrial chemicals and life sciences-related products. The company also continues to invest heavily in upgrading facilities and production capacity to support its growth plans under its mid-term strategy "FELIZ 115," targeting sales expansion to ¥100 billion within the coming years. DKS Co. Ltd. operates globally with a focus on the industrial chemicals, functional materials, and life sciences markets and maintains a diversified product portfolio tailored for B2B clients across various industries. The company employs over 1,100 people on a consolidated basis and continues to leverage a strong base of product development, manufacturing expertise, and strategic partnerships to sustain its market competitiveness and growth trajectory. This description reflects the company’s comprehensive product lines, recent financial and strategic developments, and its established history and global operations as a chemical and materials manufacturer headquartered in Kyoto, Japan. All information is current as of late 2025.